Evidence map›Paper›PMID 29494619›Full record

ArticlePLoS computational biology2018

Shared activity patterns arising at genetic susceptibility loci reveal underlying genomic and cellular architecture of human disease.

J Kenneth Baillie, Andrew Bretherick, Christopher S Haley, Sara Clohisey, Alan Gray, Lucile P A Neyton, Jeffrey Barrett, Eli A Stahl, Albert Tenesa, Robin Andersson and 25 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Host susceptibility to severe influenza A virus infection.Critical care (London, England) · 2019
    Review
  7. Article
  8. The Search for Efficacious New Therapies in Sepsis Needs to Embrace Heterogeneity.American journal of respiratory and critical care medicine · 2019
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 16 institutions in 7 countries.

J Kenneth BaillieDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-5258-793X
Andrew BretherickDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-9258-3140
Christopher S HaleyDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-9811-0210
Sara ClohiseyDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-7489-9846
Alan GrayEdinburgh Parallel Computing Centre, The University of Edinburgh, Edinburgh, United Kingdom.
Lucile P A NeytonDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Jeffrey BarrettStatistical Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Eli A StahlCenter for Statistical Genetics, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Albert TenesaDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Robin AnderssonThe Bioinformatics Centre, Department of Biology & Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
J Ben BrownDepartment of Statistics, University of California, Berkeley, United States of America.
Geoffrey J FaulknerMater Research Institute, University of Queensland, University of Queensland, Brisbane, Australia.
Marina LizioRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Ulf SchaeferDepartment for Infectious Disease Informatics, Public Health England, Colindale, United Kingdom.
Carsten DaubRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Masayoshi ItohRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.ORCID 0000-0002-1772-318X
Naoto KondoRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Timo LassmannRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Jun KawaiRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
IIBDGC Consortium
Damian MoleCentre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-6884-7302
Vladimir B BajicKing Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center, Thuwal, Kingdom of Saudi Arabia.ORCID 0000-0001-5435-4750
Peter HeutinkGerman Center for Neurodegenerative Diseases, Tübingen, Germany.ORCID 0000-0001-5218-1737
Michael RehliDept. Hematology, University Hospital Regensburg, Regensburg, Germany.ORCID 0000-0003-3992-932X
Hideya KawajiRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Albin SandelinThe Bioinformatics Centre, Department of Biology & Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-7109-7378
Harukazu SuzukiRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Jack SatsangiInstitute for Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Christine A WellsAustralian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, Brisbane Australia.
Nir HacohenBroad Institute of Harvard and MIT, Cambridge, United States of America.
Thomas C FreemanDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Yoshihide HayashizakiRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Piero CarninciRIKEN Omics Science Center, Yokohama, Japan, Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.ORCID 0000-0001-7202-7243
Alistair R R ForrestHarry Perkins Institute of Medical Research, and the Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, Perth, Western Australia, Australia.
David A HumeDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Roslin Institute · GBRIKEN · JPThe University of Queensland · AUUniversity of Copenhagen · DKBroad Institute · USCentre for Inflammation Research · GBGerman Center for Neurodegenerative Diseases · DEIcahn School of Medicine at Mount Sinai · USInstitute of Genetics and Cancer · GBKing Abdullah University of Science and Technology · SAPublic Health England · GBThe University of Western Australia · AUUniversity Hospital Regensburg · DEUniversity of California, Berkeley · USUniversity of Edinburgh · GBWellcome Sanger Institute · GB

Funding

Nonparametric methods for functional and translational genomicsR00HG006698 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BROWN, JAMES BENTLEY · 2014 to 2016
$747k
Biotechnology and Biological Sciences Research Council BB/I001107/1Biotechnology and Biological Sciences Research Council BBS/E/D/20211551Biotechnology and Biological Sciences Research Council BBS/E/D/20211552Biotechnology and Biological Sciences Research Council BBS/E/D/20211553Biotechnology and Biological Sciences Research Council BBS/E/D/20211554Medical Research Council MC_PC_U127592696Medical Research Council MC_UU_00007/10Medical Research Council MR/P008887/1NHGRI NIH HHS R00 HG006698
6 · The paper itself

Abstract

Genetic variants underlying complex traits, including disease susceptibility, are enriched within the transcriptional regulatory elements, promoters and enhancers. There is emerging evidence that regulatory elements associated with particular traits or diseases share similar patterns of transcriptional activity. Accordingly, shared transcriptional activity (coexpression) may help prioritise loci associated with a given trait, and help to identify underlying biological processes. Using cap analysis of gene expression (CAGE) profiles of promoter- and enhancer-derived RNAs across 1824 human samples, we have analysed coexpression of RNAs originating from trait-associated regulatory regions using a novel quantitative method (network density analysis; NDA). For most traits studied, phenotype-associated variants in regulatory regions were linked to tightly-coexpressed networks that are likely to share important functional characteristics. Coexpression provides a new signal, independent of phenotype association, to enable fine mapping of causative variants. The NDA coexpression approach identifies new genetic variants associated with specific traits, including an association between the regulation of the OCT1 cation transporter and genetic variants underlying circulating cholesterol levels. NDA strongly implicates particular cell types and tissues in disease pathogenesis. For example, distinct groupings of disease-associated regulatory regions implicate two distinct biological processes in the pathogenesis of ulcerative colitis; a further two separate processes are implicated in Crohn's disease. Thus, our functional analysis of genetic predisposition to disease defines new distinct disease endotypes. We predict that patients with a preponderance of susceptibility variants in each group are likely to respond differently to pharmacological therapy. Together, these findings enable a deeper biological understanding of the causal basis of complex traits.

Indexed as

Crohn DiseaseDatabases, GeneticGene Expression ProfilingGenetic Predisposition to DiseaseGenomicsHumansPromoter Regions, GeneticTranscriptome

Identifiers

PMID29494619
PMCPMC5849332
OpenAlexW2951393530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.